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C79 Reliability of Risk Factors and Scoring Systems in 
Predicting Fracturing in Metastatic Femoral Bone Lesions
Y.M. van der Linden, H.M. Kroon, P.D.S. Dijkstra,
E.M. Noordijk
Leiden University Medical Center, Leiden, The Netherlands
Objective:  In  randomised Dutch  Bone Metastasis  Study on the
palliative effect  of single  versus  multiple  fraction irradiation on
painful  bone metastases  all  impending  fractures  were  excluded
from  participation.  During  intensive  follow-up  35  fractures
occurred in 1157 patients. A subset of 102 patients with a femoral
lesion, in which 8 fractures occurred within 12 weeks after irradia-
tion (8%), was used to assess the pre-treatment fracture risk. 
Methods: Pre-treatment radiographs were collected. A radiologist,
orthopaedic surgeon and radiation oncologist independently and
without knowledge of the outcome after treatment (fracture yes/
no) scored size and extent in mm, radiographic appearance/struc-
ture/aspect, localisation, percentage of cortical involvement and
estimated  risk of fracturing. Known risk  factors  (size >2.5 cm,
cortical involvement >50% or continuing pain after irradiation)
and an adjusted Mirels’ scoring system* were applied to evaluate
effectiveness (table1). 
Results: If a score of 9 points as Mirels suggested was applied sensi-
tivity  for predicting a fracture was high but specificity  very low
(table2). The positive predictive value of Mirels was low (<10%).
Size >2.5 cm, cortical involvement >50% or continuing pain were
not predictive of fracturing. 
Conclusion:  In  this  study reliability  of  accepted risk  factors and
scoring systems in predicting fracturing in patients with a femoral
bone metastasis is low. The use of Mirels’ scoring system will lead
to  excessive  surgical  overtreatment  (positive  predictive  value
<10%). Also size >2.5 cm, cortical involvement >50% or contin-
uing pain after irradiation are not specific enough. Development of
a more sensitive scoring system is ongoing. 
C80 Predictors of Wound Complications Following Free and 
Pedicled Soft Tissue Flaps for Reconstruction After 
Excision of Soft Tissue Tumours
A. Abudu1, R.S. Bell2, A.M. Griffin2, B. O’Sullivan2,
C.N. Catton2, A.M. Davis2, J.S. Wunder2
1Royal Orthopaedic Hospital, Birmingham, United Kingdom, 2Mount 
Sinai Hospital, Toronto, Canada
113 consecutive patients with soft tissue sarcoma treated by exci-
sion and reconstructive  flaps were  studied  to assess  the  risk of
complications and to compare local tumour control with those in
whom primary wound closure was possible. Minimum follow-up
was 24 months and mean age was 55 years (16–95). The sarcoma
was located in the lower extremity in 83 and upper extremity 30
patients.  Significant  wound  complications  developed  in  37
patients  (33%). The  most  common complications were  wound
infections or partial necrosis occurring in 16% (18/113) and 13%
(15/113)  respectively.  Complete  flap  necrosis  requiring  flap
removal  occurred  in  6  patients  (5%).  Three  patients  (2.3%)
required amputation as a result of complications. Significant risk
factors for development of wound complications include location
of tumour in the lower limb compared to upper limb (relative risk
2.3, p=0.02) and use of pre-operative radiotherapy compared to
no  or  post-operative  radiotherapy  (relative  risk  2.05,  p=0.02).
There was no difference in rates of complications in patients with
free or pedicled flaps, tumours < or >5 cm, distal or proximal loca-
tion of tumour. The rates of negative excision margins (80%) and
wound complications in patients who required reconstructive flaps
were not different from that for the other patients treated at our
centre who did not require reconstructive flaps. 
Conclusion:  The use of soft tissue reconstructive flaps did not reduce
the risk of positive excision margins or the rates of wound compli-
cations. The risk of amputation secondary to flap complication or
failure is low. 
C81 Silver-Coated Tumour Endoprostheses for Prevention 
of Deep Infection
G. Gosheger1, H. Ahrens2, A. Streitbuerger1, W. Winkelmann1
1University Hospital, Muenster, Germany, 2University Children’s 
Hospital, Muenster, Germany
Deep infection of a megaprosthesis remains a serious complication
(Lit.: 8% to 35% infection rate). Silver-coated catheters proved
their effectiveness in reducing infections. This study should eval-
uate the effectiveness of a silver-coated endoprosthesis and should
exclude side effects of a large surface. 40 rabbits (titanium- versus
silver-coated  endoprostheses) were  infected  with  53 104  colony
forming units of a staphylococcus aureus. The silver group showed
significant  (p<0,05,  chi-square-test)  lower  infection  rates  (7%
versus 47%) in comparison to the titanium group. Furthermore
the  measurements  of  the  c-reactive-protein,  neutrophilic  leuco-
cytes, temperature and body weight showed significant (p<0,01)
lower signs of inflammation in the silver group. The analysis of the
silver concentration in the blood (median 1, 883 ppb) and in the
organs (0, 798–86, 002 ppb) showed elevated silver concentrations
in all compartments. But there were no pathologic changes in the
laboratory parameters (e.g. creatine kinase, GOT, GPT). In addi-
tion there were no pathologic changes in the macroscopic or the
microscopic sections  of the implant and the organs. This study
could confirm the described effect of silver-coated medical devices.
The blood concentration of silver does not state a critical concen-
tration according to literature. Furthermore the overall amount of
silver in case of a coated total femur endoprosthesis is 1,01 g silver
and does not state a critical amount according to literature. 
Conclusion:  the new silver-coated Mutars-tumour endoprosthesis is
very promising and should be clinically evaluated. 
C82 Our Experience with the Capanna Method of Limb 
Reconstruction Using Free Fibular Grafts and Cadaveric 
Allograft Report of 16 Consecutive Patients
J. Bickels1, Y. Kollender1, I. Meller1, A. Amir2, D. Leshem2,
T. Shpitzer2, A. Zaretski2, A. Ad-El2, Y. Barnea2, R. Shafir2,
J. Weiss2, E. Gur3
1Nat. Unit of Orthopedic Oncology, Tel Aviv Sourasky Medical 
Center, Tel Aviv, Israel, 2Microsurgery Unit, Tel Aviv Sourasky 
Medical Center, Tel Aviv, Israel, 3Gulhane Military Medical 
Academy, Ankara, Turkey
Introduction:   Fibular  grafts  have  become  a  common  mode  of
reconstruction after resection of long bone tumours and especially
those that require intercalary resection. The current study summa-
rizes  the  authors  experience  with  16  consecutive  patients  who
underwent  limb-sparing  resection  of  a  long  bone  tumour  and
reconstruction with a fibular graft. 
Methods: Between 1997 and 2001, 16 patients underwent recon-
struction of a bone defect with a fibular graft using the Capanna
technique  of  combined  fibular  graft,  allograft,  and  hardwareS20 EMSOS abstracts
fixation. All patients were initially diagnosed with a primary bone
sarcoma.  Twelve  patients  who  were  diagnosed  with  Ewing’s
sarcoma had a delayed reconstruction (3–5  years after primary
reconstruction with a spacer) and the remaining 4 patients with
osteosarcoma had a primary reconstruction at the time of tumour
resection. Anatomic locations of reconstructions were: femur – 12,
tibia – 4. Postoperatively, the operated extremities were immobi-
lized in a cast for 6 to 9 months during which a gradual weight
bearing  was  practiced.  Flap  viability  was  monitored  using  an
implantable  doppler  device,  a  bone  scintigraphy  that  was
performed at the 10th postoperative day, and plain radiographs. 
Results: All 16 fibular grafts were viable and united. Plain radio-
graphs performed at 3 to 5 months after surgery showed bridging
callus  formation  around  all  fibular  grafts.  None  of  the  study
patients had a major recipient or donor site complication. In two
patients a failure of the hardware fixation system was observed and
surgically repaired. 
Conclusion: The Capanna method of fibular graft reconstruction
provides a biological reconstruction of large bone defects. It is a
safe and reliable technique that is associated with good functional
outcome in the majority of the patients.
C83 Composite Grafts in the Treatment of Osteosarcoma of 
the Proximal Humerus
M. Salai, I. Dudkiewicz, A. Oran, M. Prtisch
Chaim Sheba Medical Center, Tel Hashomer, Israel
Treatment of osteosarcoma of the proximal humerus poses many
difficulties and challenges to the treating team. Between 1993 and
2000 we had treated 11 patients who suffered from osteosarcoma
of the proximal humerus by composite of massive allografts and
long humeral prosthesis. Three patients were female and 8 men,
with age range of 17–74 years. Ten patients were at stage 2-b at
presentation, one patient was 3-b. one of the patients had patho-
logic fracture at presentation. All patients received pre-operative
chemotherapy followed by limb salvage surgery and postoperative
chemotherapy. Margins were wide in all patients. Postoperative
complication  included  non-union at  the  allograft/host  junction
(which united after auto grafting) and superficial wound infection,
which  resolved  after  antibiotic  therapy.  A  team  of  orthopedic
oncologist and shoulder surgeon performed all operations. At latest
follow-up (December 2001), all patients except one (with 3-b at
presentation) are alive, with good functioning upper limb. 
Conclusion:  the  team  approach  of  orthopedic  oncologist  and
shoulder surgeon contributed largely to the good surgical results,
and hence the survival and function. We suggest implementation
of such team approach also in other fields of orthopedic oncology:
spine, hip, knee etc.
POSTER PRESENTATIONS
C84 CAD Supported Planning with Stereo Lithography 
Model in Bone Tumours of the Pelvis
C. Gebert, J. Hardes, B. Leidinger, G. Gosheger, W. Winkelmann
Dept. of Orthopaedics, University Hospital, Muenster, Germany
Long term survival of malignant bone tumours is strictly correlated
to the wide resection of the tumour. Especially, in tumours of the
pelvis, a correct estimation of the resection is necessary. Typically,
there were used CT scans or MR images and sometimes surface-
models  manufactured  in  CNC  technique.  Despite  this  3-D-
reconstruction technique, it was not possible to get information
about the intra-cortical tumour expansion. In lithography, each
partial  volume  of  the  CT-scan  is  expressed  in  a  proportional
volume of the plastic model. With Stereolithography the estima-
tion of the tumour expansion is much easier, because the intracor-
tical tumour defect component is visualised by a ‘defect’ in the
model. Using the model, it is possible to produce individual metal
blocks supporting the correct resection. It is essential to perform an
exact resection for the primary fit of pelvic (partial-) prosthesis. In
our department we treated three patients by internal hemipelvec-
tomy with the help of stereolithography models. The primary bone
contact  of  the prostheses  was  quite  good in all  patients  with a
shortening  of  the  time  needed  for  the  operation  compared  to
former resection techniques in pelvis tumours. 
Conclusion:  With the help of CAD-techniques in combination with
models  manufactured  in  lithography  technique  there  can  be
achieved an exact resection if there is a good interaction between
the surgeon and the prosthesis manufacture. 
C85 Transosseus Osteosynthesis (TO) in the Treatment of 
Pathological Fractures (PF).
V.V. Tepliakov, I.M. Lebedenco, E.E. Kovalevskii, M.D. Aliev
Blokhin Cancer Center, Moscow, Russian Federation
Purpose: to show an opportunity of TO in combined treatment of
patients with PF of long tubular bones. 
Methods:  there were  31  PTAs: 10  men,  21  women. Age range
17–70. PF occurred in 13 cases of breast cancer metastases, 3- of
renal cancer, 2- of cancer of the stomach and the oesophagus, 2-
metastases  without  detected  primary,  2-metatsases  of  Eking
sarcoma, 3- of lymphosarcoma, 2- of osteosarcoma. And metas-
tases  from  MFH,  melanoma,  fibro-osseous  dysphasia,
lymphogranulomatosis – each for 1 case. The localization of the PF
was: neck of femur- 10 cases, proximal-8 and distal-4 metadia-
physes of femur, 5- diaphysis of femur. The humerus: 3 in the
diaphysis, 1- neck of humerus. TO was held in time of 11 days after
PF. 19 patients received radiation therapy single dose 4 Gy, SD
20–59 Gy. 2 patients received radiation therapy in combination
with intraarterial chemotherapy, 13- in combination with i/v chem-
otherapy and hormonal therapy. 6 patients received only chemo-
therapy, hormonal therapy or immunotherapy. 5 patients didn’t
receive any additional treatment. 
Results: 16 patients reached complete consolidation after 152 days.
4 patients after TO and conservative therapy received wide resec-
tions  with  allografts  or  autografts  with  vascularised  bone.  The
mean follow up period was 36.5 months. Good functional results
were achieved in 14 patients. Satisfactory results were achieved in
6 patients. 11 patients died from disease progression. In the time
of 6.5 months after TO. 
Conclusion:  TO allows one to reach consolidation of the fracture
and to  add chemotherapy or radiation therapy. In the cases of
favourable prognosis and the absence of consolidation its possible
to make salvage operations (arthroplasty, auto- or allo- bone grafts
implanting). 
C86 The Role of Microsurgery in Orthopedic Oncology: A 3-
Years Experience with 39 Cases of Limb-Sparing Surgery
J. Bickels1, Y. Kollender1, I. Meller1, A. Amir2, D. Leshem2,
T. Shpitzer2, A. Zaretski2, A. Ad-El2, Y. Barnea2, R. Shafir2,
J. Weiss2, E. Gur3
1Nat. Unit of Orthopedic Oncology, Tel Aviv Sourasky Medical 
Center, Tel Aviv, Israel, 2Microsurgery Unit, Tel Aviv Sourasky 
Medical Center, Tel Aviv, Israel, 3Gulhane Military Medical 
Academy, Ankara, TurkeyEMSOS abstracts S21
Introduction:  Limb sparing-resections of large tumours are associ-
ated with the creation of large bone and soft-tissue defects. Avail-
ability of microsurgical techniques allows reconstruction of such
defects  that  otherwise  would have require  an amputation. The
current study summarizes a 3-years experience with microsurgical
reconstructions following limb-sparing resections. 
Material  and  Methods:  Between  1998  and  2001,  39  patients
required microsurgical intervention. There were 25 males and 14
females who ranged in age from 8 to 42 years. Diagnoses included:
primary bone sarcomas – 31, soft tissue sarcomas – 8. Anatomical
locations were: femur – 25, tibia – 4, radius – 4, humerus – 1, fibula
– 1, heel – 3, and forearm – 1. Primary microsurgical reconstruc-
tion following tumour resection was performed in 11 patients and
delayed reconstruction (after primary bone reconstruction with a
spacer or as a treatment of late infection) in the remaining 28. A
fibular graft was used for reconstruction of intercalary bone defect
in 19 patients, knee arthrodesis – 2, distal radius reconstruction –
4, and proximal humerus reconstruction – 1. Eight patients had
soft tissue reconstructions (Latissimus dorsi flap – 1; scapular flap
– 1; gracilis muscle flap – 1). 
Results: At the most recent follow-up, all bone and soft-tissue flaps
were united and viable, respectively. None of the study patients
had infection or local tumour recurrence. Only one patient had a
mechanical  failure  of  internal  fixation  implant  that  required  a
secondary reinforcement. 
Conclusion:   Microsurgical  techniques  of  reconstruction  allow  a
limb-sparing resection of large bone and soft-tissue tumours that
otherwise  would  necessitate  and  amputation.  Microvascular
reconstructions  are  associated  with  high  rate  of  success  and
provide a functional extremity in the majority of the patients. 
C87 Limb-Salvage Surgery for Malignant Musculoskeletal 
Tumours in Children
A. Shchurovsky, I. Lukavetskyj, O. Mohylyak, T. Pidlisetsky
Lviv Regional Specialised Children’s Clinic, Lviv, Ukraine
Objective  of  study:  Limb-salvage  surgery  for  malignant  bone
tumours  has  become  the  standard  method  of  treatment.  The
longevity, complications and functional results of these methods
vary according to anatomic location, age and type of surgery. 
Methods: Between January 1993 and January 2002 were treated 63
patients. Due to the fact that the majority of patients were admitted
in late stage of disease only in 30 of them ( 21 males and 9 females)
underwent the limb-salvage procedures. The age ranged from 1 till
18 years (mean- 14,3 years). The diagnosis were: Osteosarcoma –
13 patients , Ewing’s Sarcoma – 6, Malignant Giant Cell Tumours
– 3, Soft-Tissue Tumours – 3, Chondrosarcoma – 2 and Malignant
Fibrous Histiocytoma  –  1 patient. The  tumour locations  were:
proximal femur – 1 patient, distal femur – 11, proximal tibia – 2,
proximal fibula – 4, distal fibula – 1, proximal humerus – 5, pelvis
– 1, ribs – 3, forearm – 1 patient and hand in one case. For these
patients were performed different types of limb-salvage surgery:
prosthetic  replacement  –  12  patients,  resection  –  12  patients,
resection  with  allo-,  auto-  or  ceramoplasty  in  5  patients,  and
rotationplasty in one case.
Results: The earliest follow-up for prosthetic replacement was 60
months , for resection-reconstruction – 36 months and after resec-
tion  – 64  months. The function was excellent  and good in  11
patients after prosthetic replacement (91,6%), in 4 patients after
resection – reconstruction (80%) and in 10 patients after resection
(83,3%).
Conclusion:  The best functional results were received in patients
after prosthetic replacement. This kind of treatment has faster and
better aesthetic effect in comparison with the other limb-salvage
surgery techniques. This positively effects psychological and social
aspects of such patients. 
C88 Our Experience of Using Revascularised Flaps in 
Oncology
V.A. Sobolevskyi, M.A. Kropotov, E.G. Matiakin, M.D. Aliev
Blokhin Cancer Center, Moscow, Russian Federation
The  use  of  microsurgical  reconstructive technique  in  oncology
affords to reach more radical incision of the tumour from one side,
and to increase functional and cosmetical results from another. In
our study we reviewed 29 pts. The localization of the lesion was:
15- lower extremities  (in 4 cases- benign tumours), 5pts- upper
extremities, 8- head and neck,1 pt – abdominal wall localization.
There  were  primary  bone  tumours  in  14  cases,  7  cases-  skin
tumours, 5-soft tissue sarcomas, 3 pts with the mucous tumours of
oral cavity. There were locally advanced lesions in all cases, that
why it was impossible to execute salvage operation or to close the
defect with local tissues. We used bone plasty in 15 cases: 8 – tibial
bone, 4- bones of the forearm, 3 mandibular bone. In one case for
closing defect of head skin and temporal bone we used the frag-
ment of omentum. Most often we used vascularised fibular bone-
13 cases, 1 combined scapular flap, 1 iliac bone flap. Soft tissue
defects were replacing in 14 pts, in three cases radial forearm flap
and thoracodorsal flap (8 pts), scapular flap (2 pts). Complications
were  observed  in  6  (20,7%)  pts:  flap  necrosis  -4  pts  (13.8%),
wound infection in 2 pts. Follow up period was 2 years, and there
were 2 cases of recurrence. 1 pt died from generalization. 
Conclusion:   The  use  of  microsurgical  reconstruction  technique
allows to reach good functional and cosmetic results with favour-
able oncological prognosis. 
C89 Surgical Management of Humeral Metastases Princi-
ples of Surgical Intervention, Functional, and Oncological 
Outcomes
J. Bickels1, J.C. Wittig2, R. Oren1, Y. Kollender1,
K. Kellar-Graney2, M.M. Malawer2
1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
2Washington Cancer Institute, Washington, USA
Introduction:  Metastatic-bone-disease of the humerus may be asso-
ciated  with  disabling  pain  and  loss  of  function.  Surgery  must
provide  good  local  tumour-control,  immediate  mechanical-
stability,  and  a  short  rehabilitation-period.  Between  1980  and
2000, the authors operated 47 patients with metastatic disease of
the humerus. The current study summarizes the principles of the
surgical technique and functional and oncological outcomes. 
Methods: There were 26 females and 21 males who ranged in age
from 34 to 76 years. Forty-one patients presented with an impending
or pathological fracture and 6 had intractable pain. Anatomic loca-
tions of humeral metastases included: around the proximal humeral
metaphysis and head (Type I) – 14, humeral diaphysis (Type II) –
32, and humeral condyles (Type III) – 1. Types I and III metastases
were treated with resection and endoprosthetic reconstruction. Type
II metastases were treated with intralesional tumour removal and
cemented internal fixation. Motion of the operated extremity was
allowed immediately after surgery. Postoperatively, 32 patients were
treated with radiation therapy and 10 with chemotherapy. Follow-up
of  the  study  patients  included physical  examination, radiological
evaluation  and  functional  evaluation  according  to  the  American
Musculoskeletal Tumour Society system. 
Results: Following surgery, all patients had a stable and painless
extremity.  Function  was  good-to-excellent  in  38  patients  and
moderate in 9 patients. Thirty-one (66%) patients survived more
than 1 year and 19 (40%) survived 2 years after surgery with local
tumour recurrence occurring in only one patient. 
Conclusion:  The anatomic location of humeral metastasis dictates
the mode of tumour resection  and reconstruction: periarticular
tumours are treated with endoprosthetic replacement and diaphy-
seal tumours with curettage and cemented internal fixation. AnS22 EMSOS abstracts
aggressive surgical approach and judgmental use of adjuvant treat-
ment  modalities  achieve  good  functional  outcomes  and  local
tumour control in the majority of these patients. 
C90 Limb Salvage Surgery and Implantation of Mega – 
Endoprothesis in 62 Patients with Bone Tumours
D. Orlic, M. Smerdelj, R. Kolundzic, O. Ivna
Dept. of Orthopaedic Surgery, University of Zagreb School of Medicine, 
Zagreb, Croatia
Special modular uncemented endoprostheses from 1987 to 2001
were implanted in 62 patients after ‘en bloc’ resection. The most
often  indications  were  malignant  bone tumours  in  44  (69,3%)
patients, benign bone tumours in 11 (17,7%) massive destruction
of  the  proximal femur or instability  of hip endoprosthesis  in  4
(6,4%) and tumours like lesions in 3 (4,8%). Osteosarcoma was
mostly resected malignant bone tumour in 21–33,9% of all oper-
ated (!) patients, Ewing sarcoma in 9, chondrosarcoma in 6, metas-
tasis in 2, fibrosarcoma, synoviosarcoma, angiosarcoma, periosteal
osteosarcoma,  MFH,  angiosarcoma  and  leiomyosarcoma  in  1
patient respectively. Salvage surgery was performed in 38 knee and
24 hip joints. The median length of proximal femoral resection was
17 cm; of distal femur 15,4 cm, and 13 cm of proximal tibia. 
Results of treatments were analysed: 42 patients (67,7%) showed no
evidence of disease at the last follow-up; 2 (3,2%) changed the
state of living and we are without any information, and 18 patients
(29%)  had  died.  Additional  postinfective  complications  (as
contracture of  the  knee joint  in  two  patients,  fused  knee after
salvage surgery, luxation of endoprosthesis and the girl with hepa-
titis and salvage hip surgery is waiting for reoperation) were regis-
tered in 4/62 patients. With the aid of contemporary chemotherapy
limb salvage surgery is and will be a great challenge for orthopaedic
oncologists of the 21st century. 
C91 ‘Endlock’ Stem Design for Anchorage of Massive 
Reconstruction Endoprostheses.
G.U. Exner1, HAC Jacob1, R. Bedzinski2
1Univ. of Zurich, Zurich, Switzerland, 2Technical University, 
Wrozlaw, Poland
Rationale: Most anchoring stems for cementless fixation produced
currently are designed for bone adherence or ingrowth over the full
length. While ensuring good primary stability, they have the draw-
back  of  stress-shielding  resulting  in  resorption  of  bone  in  the
proximity of the insertion site at the resected end of the bone.
Methods: We have therefore designed a stem system made of cobalt
chromium exhibiting a smooth polished surface at the far end and
a fixation region presenting a scalloped surface plasma coated with
pure titanium for over a length of about 3 cm towards the joint.
This limits force transmission from the endoprosthesis to the host
bone  only  within  a  short  distance  at  the  insertion  site.  Finite
element analysis has proved that the system can bear the loads
imposed and that the bone is adequately loaded along its whole
length, thereby ensuring that the bone is not subjected to stress-
shielding and subsequent atrophy. 
Patients:  The  system  was  used  in  6  osteosarcoma  patients  for
primary implantation, and in 4 patients for the revision of loosened
conventional stems. 
Results:  In  2  cases  of  primary  implantation  loosening  occurred
needing replacement, for which larger stems of the same design
were used; in all cases loosening was related to splitting of the bone
at the time of surgery. All other cases including all the revision
cases remained stable at 2–3 years f/u with no signs of bone atrophy
due to stress shielding. 
Conclusion:  The hypothetical assumptions related to stem design
have been confirmed through finite element analysis. In clinical
application  some  technical  aspects  of  preparing the  bone need
improvement. If primary stability is achieved, long term prognosis
appears to be improved by the system. Stress-shielding is reduced
compared to conventional long stems.
C92 Surgery and Radiotherapy as Combined Treatment for 
the Primary Management of Pigmented Villonodular 
Synovitis of the Foot and Ankle 
M Lee, S Mahroof
TWR Briggs Bone Tumour Unit Royal National Orthopaedic Hospital,  
Stanmore, UK
Surgery is the mainstay of treatment for pigmented villonodular
synovitis (PVNS), whether local excision for the nodular form, or
total synovectomy for diffuse cases. Radiotherapy has been used in
the  management  of  recurrences,  but  is  not  routinely  part  of
primary treatment. A previous study combining radiotherapy and
synovectomy has reported encouraging results with regard to the
knee. We present the results of combined synovectomy and low
dose external beam radiotherapy in the primary management of
PVNS of the foot & ankle. 7 patients with clinical, MRI and histo-
logically confirmed PVNS of the foot & ankle were followed in a
prospective study between 1997 and 1999 at the Royal National
Orthopaedic  Hospital.  The  patients  underwent  synovectomy,
followed by radiotherapy with a total dose of 30Gy. One surgeon
performed the operation. At an average follow-up of 26 months, 6
of the 7 patients (85%) reported persistent swelling and pain, and
was found to have a recurrence of the lesion. we believe that using
a low dose of radiotherapy in conjunction with surgical excision of
a primary PVNS lesion in the foot and ankle may reduce the risk
of recurrence without impairing joint mobility.
C93 Repair of Bone Defects, Which Occurred During 
Treatment of Bone Tumours, with Ilizarov Bone 
Transportation Method
K. Erler, M. Basbozkurt, C. Yildiz, E. Gur
Gulhane Military Medical Academy, Ankara, Turkey
Objective of Study: To repair bone defects, which occurred after en
block resection during malign or aggressive benign bone tumour
surgery, with bone transportation method described by Ilizarov. 
Methods: 8 cases, on whom en block resection was performed due
to  bone  tumours  were  treated  by  Ilizarov  bone  transportation
method between October 1991 – June 2001 in our clinic. Six were
male, and 2 were female. There was one case with distal femur
osteosarcoma,  one  with  tibial  osteofibrous  dysplasia,  one  with
tibial aggressive osteoblostoma, one with giant cell tumour at tibia,
one  with  tibial  diaphyseal  osteosarcoma,  and  two  with  Ewing
sarcoma at femur. After en block resection was performed, bifocal
CEF (circular external fixator) was applied and corticotomy was
done  at  either  proximal  or  distal  metaphysis.  Distraction  was
started on the 4th – 7th day and continued 43 0.25 mm every day.
Ilizarov  frame was removed when sufficient bone consolidation
was  observed  in  follow-up  radiograms.  During  the  follow-up
period, the patients continued rehabilitation program. 
Results:  The  average follow-up period was 46  months,  and the
average duration of CEF was 15 months. The average length of
bone defect after tumour resection was 16.5 cm (11–23). Skin fold
occurred in one patient and was treated by an operation. Bone
marrow injection was used in one case with delayed union. One
case had supracondylar femur fracture due to falling down during
the follow-up period so open reduction and internal fixation wasEMSOS abstracts S23
performed. Pin tract infection was observed in five patients and
they were treated by antibiotic therapy and dressing. Restriction of
the range of motion was observed in one case. 
Conclusion:  We observed that the bone transportation method of
Ilizarov is an alternative method for the repair of bone defects that
occurred during the treatment of bone tumours. 
C94 Endoprosthetic Reconstruction of the Upper Extremity 
Using the Trevira Tube
G. Gosheger1, C. Gebert2, J. Hardes1, W. Winkelmann1
1University Hospital, Muenster, Germany, 2University of Muenster, 
Muenster, Germany
To avoid dislocation of an unconstrained endoprosthesis a special
trevira  tube  (polyethylene  terephthalate)  was  developed.  The
trevira tube is a knitted tube belonging to the Modular Tumour
and Revision  System  (Mutars®, Implantcast  Corp, Buxtehude,
Germany). It is characterized by a porous structure of 200 mm and
a tensile strength of 4000 N. This tube is attached to the rest of the
capsular structures. The tube is fixed to the megaprosthesis and
the muscles  are reattached to the prosthesis.  A  non-absorbable
suture is used for all attachments to the trevira tube. In the case of
proximal  humerus  replacement  (16  patients),  the  trevira  tube
allows  for  reconstruction  of  the  capsule  and  refixation  of  the
muscles. By using the trevira tube in proximal humerus replace-
ment, the complete rotator cuff was reattached in 11 patients, only
the subscapular muscle was reattached in three patients, and only
the supraspinatus muscle could be reattached in two patients. No
dislocation was observed in patients with proximal humerus endo-
prosthesis. The mean active abductor motion against gravity was
37.5º (range, 0º–75º), the anteversion was on average 35.0º (range,
5º–79º), and active ROM of internal rotation was on average 15.2º
(range,  10º–35º)  and  external  rotation  was  on  average  25.2º
(range, 15º–45º),  but  there  was  an  increased  range  of  passive
motion  in  these  patients  especially  in  external  rotation  (up  to
120º). The mean overall functional outcome of patients with a
proximal  humerus  replacement  was  70.4%  (range, 46%–83%)
according to the Musculoskeletal Tumour Society score. There
was no significant increase in the rate of infection (p = 0.46; chi
square  test).  The  histopathologic  findings  showed  a  tissue
ingrowth  into  the  tube.  In  proximal  humerus  replacement  the
trevira  tube  provides  safe  protection  against  dislocation,  the
abductor capability could not be improved as predicted previously. 
C95 Gait and Function in Patients with a Femoral 
Endoprosthesis After Tumour-Resection 18 patients 
evaluated 11,8 years after surgery
J.C. Rompen, S.J. Ham, J.P.K. Halbertsma, J.R. Van Horn
University Hospital Groningen, Groningen, The Netherlands
We performed gait analysis in 18 patients with a femoral endopros-
thesis; 12 distal, 3 proximal and 3 total femoral endoprostheses.
Follow-up after tumour resection and reconstruction was mean 12
(0.5–19) years. Measured gait parameters were walking velocity,
steplength, duration of stancephase and swingphase. Furthermore,
goniometry of the hip, knee and ankle in both legs was performed
during free paced walking. The functional outcome score of the
Musculoskeletal Tumour Society  (MSTS) and the  Ambulation
score were also performed in all patients. The mean free paced
walking velocity was 88% of normal. The steplength of the non-
involved leg was longer than that of the involved leg. The swingphase
of the involved leg was longer compared to the non-involved leg,
and the stancephase of the involved leg was shorter compared to
the non-involved leg. Goniometry revealed three abnormal patterns
in the involved leg; a stiff knee gait was observed in 10 patients, and
a flexed knee gait in 6. An abnormal flexion-extension pattern in
the hip was observed in 9 patients. Goniometry of the non-involved
leg was normal. The mean MSTS score was 22 points (72%). The
MSTS score was significantly positively correlated to the Ambula-
tion score, but was not significantly correlated to any of the meas-
ured temporal variables. Our findings indicate that time of load on
the involved leg, whether consciously or not, is reduced. Follow-up
studies are necessary to evaluate the effects of the observed asym-
metrical gait pattern and the abnormal goniometric results on the
development of endoprosthesis-related complications. 
C96 Should Soft Tissue Sarcomas be Treated at a Specialist 
Centre?
AA Bhangu1, RJ Grimer2
1University of Birmingham, Birmingham, United Kingdom, 2Royal 
Orthopaedic Hospital, Birmingham, United Kingdom
Aim:  ‘Cancer  should  be  treated  by  cancer  specialists’  is  often
stated, but little proof exists that outcomes are different. We have
investigated whether there is evidence that patients with soft tissue
sarcomas do better if treated in a specialist centre compared with
district general hospitals. 
Methods: We analysed the outcomes for all patients with soft tissue
sarcomas in one health region of the UK over a 3 year period, with
minimum follow up of 4 years. During this time half of patients
were treated at a specialist musculoskeletal oncology centre whilst
the remainder had treatment centred in a DGH. We have investi-
gated appropriateness of treatment, adequacy of surgery, use of
adjuvant treatment  and outcomes in terms  of local control and
overall survival. Data was obtained from the Cancer Intelligence
Unit and the specialist centre. Results are stratified for known risk
factors for local control and survival (margins, grade/size for LR;
depth, size and grade for survival). 
Results: 296 patients were diagnosed as having STS over the 3 year
period (incidence = 1.71 per 100,000 per year). Half of patients
had the majority of treatment at the specialist centre under the care
of 2 surgeons, whilst the other half were treated by a total of 105
different surgeons. Care at the specialist centre involved staging,
biopsy, excision (wide margins if possible) and adjuvant radio-
therapy. Care at DGHs was haphazard and only a minority had
appropriate staging. Overall survival of ROH patients at one year
is 87.8% compared to 72.5% of patients not seen at the ROH, and
was  slightly  worse  at  five  years  with  55.8%  survival  for  ROH
patients and 50.6% survival elsewhere. Patients treated at DGHs
had significantly more local recurrences. 
Conclusion:   Soft  tissue  sarcomas  are  rare.  Centralization  of
treatment improves patients care and improves local control. 
C97 Single Dose Versus Fractionated Irradiation in 
Metastatic Femoral Bone Lesions: Assessment of
Fracture Risks
Y.M. van der Linden, E.M. Noordijk, P.D.S. Dijkstra,
H.M. Kroon
Leiden University Medical Center, Leiden, The Netherlands
Objective: In randomised Dutch Bone Metastasis Study on pallia-
tive effect of single versus multiple fraction irradiation on painful
bone  metastases  all  impending  fractures  were  excluded  from
participation.  During  follow-up  35  fractures  occurred  in  1157
patients. 24 fractures developed after single dose 8Gy (4%), 11
after 6 fractions of 4Gy (2%) (p<0.05). Whether this difference
was caused by insufficient total dose or by lesion-related factors
(size, cortical involvement, localisation) was unknown. A subset ofS24 EMSOS abstracts
102 patients with femoral lesions, in which 10 fractures occurred
in 46 single dose (22%) and 3 in 57 multiple dose patients (5%),
was used to assess the pre-treatment fracture risk. 
Methods: Pre-treatment radiographs were collected. A radiologist,
orthopaedic surgeon and radiation oncologist independently and
without knowledge of the outcome after treatment (fracture yes/
no)  scored  size  and  extent,  radiographic  appearance/structure/
aspect, localisation, percentage of cortical involvement (<50% or
>50%) and expected risk of fracturing (<50% (low risk) or > 50%
(high risk)). 
Results:  In  multivariate  analysis  only  estimated  risk  of  frac-
turing  was  significant  in  observers  1  and  2  (p<.001  and
p=.001).  Multiple  fractions  proportionally  reduced  the  risk  of
fracturing in high risk and low risk lesions in all observers (not
significant). 
Conclusion:   Multiple  fractions  reduce  the  risk  of  fracturing,
especially in high risk lesions (expected risk of fracturing > 50%)
although not significant. Accurate detection of high risk lesions is
observer-related. Developing of scoring system to assess risk on
fracturing is ongoing. 